What Are Bispecific Antibodies, and Why Do They Matter?
Bispecific antibodies are engineered therapeutic molecules designed to simultaneously bind two distinct antigens or epitopes. This dual targeting capability enables powerful and differentiated mechanisms of action, including immune cell redirection, enhanced tumor selectivity, dual checkpoint inhibition, and coordinated modulation of multiple disease pathways.
What Are Bispecific Antibodies, and Why Do They Matter?
Bispecific antibodies are engineered therapeutic molecules designed to simultaneously bind two distinct antigens or epitopes. This dual targeting capability enables powerful and differentiated mechanisms of action, including immune cell redirection, enhanced tumor selectivity, dual checkpoint inhibition, and coordinated modulation of multiple disease pathways.
By integrating multiple biological functions into a single molecule, bispecific antibodies offer new possibilities across oncology, immunology, infectious disease, and other complex disease areas. This unlocks therapeutic strategies that are not achievable with conventional monospecific antibodies alone.
Our Bispecific Design Services
We deliver tailored bispecific antibody design strategies grounded in decades of antibody engineering expertise and a deep understanding of complex molecular architectures.
Format Selection & Target Pairing
We guide optimal format selection (IgG-like or fragment-based) based on your biological targets, intended mechanism of action, and therapeutic context.
Fc Engineering & Structural Optimization
Our team designs and optimizes Fc regions to achieve the desired balance of half-life, effector function, and manufacturability aligned with your program goals.
Expression Optimization
We ensure balanced expression and accurate chain pairing through optimized vector design and robust expression systems.
In Silico Developability Assessment
Advanced sequence liability screening and structure-based analysis identify potential risks early, supporting informed design decisions and streamlined humanization.
Sequence Engineering & Humanization
We provide sequence engineering, codon optimization, and CDR grafting to enhance compatibility, reduce immunogenicity, and prepare your molecule for downstream development.
Bispecific Antibodies Are Powerful, but could be Challenging to Build
Designing bispecific antibodies is complex. Even with a strong concept, developers frequently encounter hurdles such as:
- Heavy and light chain mispairing
- Structural instability
- Low expression yields
- Aggregation or misfolding
- Manufacturing difficulties
These challenges can slow development and compromise functionality. That’s why working with Fusion Antibodies matters. With deep expertise in structural biology, rational engineering, and proprietary in silico tools, we know how to navigate these difficulties and deliver stable, functional bispecifics tailored to your therapeutic goals.
Bispecific Formats We Support
| Format | Description |
|---|---|
| Knob-in-Hole IgG | Facilitates correct heavy chain heterodimerization using structural mutations. |
| CrossMab | Enables light chain pairing control by domain swapping. |
| Dual Variable Domain (DVD-Ig) | Two variable regions stacked on a single chain for dual binding. |
| scFv-Fc Fusion | Combines small size with Fc stability and function. |
| Tandem scFv (BiTE) | Two scFvs connected for T cell redirection, ideal for immuno-oncology. |
| IgG-scFv | An IgG backbone with a fused scFv arm for tri-specific potential or steric flexibility. |
| Two-in-One Antibodies | Single binding site engineered to recognize two distinct antigens. |
From design through to transient gene expression and bespoke purification, we optimise challenging molecules for performance, scalability, and manufacturability
We can also explore custom and emerging formats in collaboration with your R&D team
Tell us what you’re working on.
Share the useful starting details and your enquiry will be sent securely to Fusion’s scientific team.